Is a Benign Disease Course Possible in Untreated <scp>AQP4</scp>‐<scp>IgG NMOSD</scp>?
The presence of benign NMOSD and the potential for safe de-escalation of therapy in NMOSD remains unclear. This study suggests that both may be possible. Further studies of similar cases could provide valuable insights and identify biomarkers for safe treatment discontinuation.
Authors
- Samantha Linaker
- Chiara Rocchi (ORCID: https://orcid.org/0000-0002-1215-9583)
- Patricia Jane Kelly (ORCID: https://orcid.org/0000-0002-8143-7153)
- Emily Gibbons (ORCID: https://orcid.org/0000-0003-0470-1499)
- Saif Huda (ORCID: https://orcid.org/0000-0003-0980-3750)
- Pakeeran Siriratnam (ORCID: https://orcid.org/0000-0003-4751-2102)
Institutions
- University of Liverpool (GB)
- Walton Centre (GB)
- Alfred Health (AU)
- Monash University (AU)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/ene.70049
- Citations
- 6
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.83